tiprankstipranks
Trending News
More News >
Hannover Rueck (DE:HNR1)
XETRA:HNR1

Hannover Rueck (HNR1) AI Stock Analysis

Compare
47 Followers

Top Page

DE:HNR1

Hannover Rueck

(XETRA:HNR1)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 5.2)
Rating:68Neutral
Price Target:
€269.00
▲(10.16% Upside)
The score is supported primarily by solid financial strength (profitability and improving leverage), plus an appealing valuation (12.07 P/E and 3.64% yield). These are tempered by weak technicals, with the stock trading below key moving averages and negative momentum indicators.
Positive Factors
Revenue Growth
Consistent revenue growth reflects strong market demand and effective business strategies, supporting long-term expansion and stability.
Cash Generation
Strong cash generation enhances liquidity and financial flexibility, enabling investment in growth opportunities and shareholder returns.
Balance Sheet Strength
A strong balance sheet with low leverage reduces financial risk and supports sustainable growth and resilience in market downturns.
Negative Factors
Net Income Fluctuations
Fluctuations in net income can signal volatility in earnings, potentially impacting investor confidence and long-term financial planning.
Profitability Concerns
A decline in net income may indicate challenges in maintaining profitability, which could affect future earnings and investment capacity.
Earnings Volatility
Earnings volatility can reflect underlying business uncertainties, potentially impacting strategic decisions and investor sentiment.

Hannover Rueck (HNR1) vs. iShares MSCI Germany ETF (EWG)

Hannover Rueck Business Overview & Revenue Model

Company DescriptionHannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The company offers property, casualty, facultative, catastrophe XL, structured reinsurance, and insurance-linked securities. It also provides risk solutions for agricultural, livestock, and bloodstock businesses; aviation and space business; and marine and offshore energy business, as well as credit, surety, and political risks reinsurance products. In addition, the company offers group and individual credit life, enhanced annuities, group life and health, and Takaful reinsurance products; and risk solutions in the areas of critical illness, disability, health, longevity, long term care, mortality, and morbidity. Further, it provides various financial solutions, including new-business financing; monetization of embedded value; reserve and solvency relief; and divestiture of non-core businesses. The company was formerly known as Hannover Rückversicherung AG and changed its name to Hannover Rück SE in March 2013. The company was founded in 1966 and is headquartered in Hanover, Germany. Hannover Rück SE is a subsidiary of Talanx AG.
How the Company Makes MoneyHannover Rueck generates revenue primarily through its reinsurance activities, which involve assuming risk from primary insurers in exchange for premium payments. The company's key revenue streams include premiums from property and casualty reinsurance, life and health reinsurance, and specialty lines of business. Additionally, Hannover Rueck invests the premiums received in various financial instruments, generating investment income. Significant partnerships with insurance companies globally enhance its market presence and contribute to its earnings, while a strong focus on risk management and underwriting discipline allows the company to maintain profitability and manage claims effectively.

Hannover Rueck Financial Statement Overview

Summary
Strong profitability and return profile (TTM net income ~2.47B; ~21% ROE) and a sound, improving leverage position (debt-to-equity ~0.35 vs ~0.68 in 2022). Offsetting factors are volatility in margins across years and weakened cash conversion, with TTM free cash flow down sharply (~-40%) and covering ~46% of net income.
Income Statement
74
Positive
Profitability is strong, with TTM (Trailing-Twelve-Months) net income of ~2.47B and a high return profile supported by ~21% return on equity. Revenue growth improved to ~8.7% in TTM versus low-single-digit growth in 2024, showing better top-line momentum. Offsetting this, margins and revenue levels appear volatile across periods (including unusually high profit margins in TTM and 2024 versus much lower margins in 2022–2023), which raises questions around earnings consistency and comparability year to year.
Balance Sheet
79
Positive
The balance sheet looks sound for a reinsurer, with moderate leverage and improving capital positioning: debt-to-equity is ~0.35 in TTM (Trailing-Twelve-Months) versus ~0.68 in 2022, and equity is sizable at ~12.0B. Total assets are large (~70.3B), indicating scale. The main watch item is that absolute debt remains meaningful (~4.19B) and assets fluctuate year to year, so maintaining capital strength through underwriting cycles remains important.
Cash Flow
63
Positive
Cash generation remains solid on an absolute basis (TTM (Trailing-Twelve-Months) operating cash flow ~5.31B and free cash flow ~2.46B). However, free cash flow fell sharply in TTM (about -40% growth), and free cash flow covers less than half of net income in TTM (~46%), suggesting earnings-to-cash conversion weakened versus prior annual periods where free cash flow closely matched net income. This introduces more volatility risk in cash returns and capital flexibility.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.25B2.66B1.13B1.39B26.28B23.17B
Gross Profit1.25B2.53B1.04B1.31B26.28B23.17B
EBITDA3.42B3.37B2.01B1.44B1.71B1.44B
Net Income2.47B2.33B1.82B780.80M1.23B883.07M
Balance Sheet
Total Assets70.35B72.13B65.67B62.96B82.90B71.44B
Cash, Cash Equivalents and Short-Term Investments56.51B57.39B1.05B46.65B47.59B1.28B
Total Debt4.19B4.67B4.77B5.51B4.37B3.43B
Total Liabilities57.45B59.44B54.65B53.00B70.15B59.60B
Stockholders Equity12.00B11.79B10.13B9.06B11.89B11.00B
Cash Flow
Free Cash Flow2.46B5.68B5.79B4.95B4.94B3.02B
Operating Cash Flow5.31B5.68B5.79B4.95B4.94B3.02B
Investing Cash Flow-3.84B-4.41B-4.51B-5.08B-5.26B-2.03B
Financing Cash Flow-1.72B-1.10B-1.50B44.30M277.51M-726.04M

Hannover Rueck Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price244.20
Price Trends
50DMA
252.17
Negative
100DMA
252.96
Negative
200DMA
259.89
Negative
Market Momentum
MACD
-4.35
Negative
RSI
48.47
Neutral
STOCH
61.27
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:HNR1, the sentiment is Neutral. The current price of 244.2 is above the 20-day moving average (MA) of 242.05, below the 50-day MA of 252.17, and below the 200-day MA of 259.89, indicating a neutral trend. The MACD of -4.35 indicates Negative momentum. The RSI at 48.47 is Neutral, neither overbought nor oversold. The STOCH value of 61.27 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for DE:HNR1.

Hannover Rueck Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
€66.94B10.8819.40%3.56%0.48%11.17%
68
Neutral
€28.79B11.6621.34%3.37%2.57%9.75%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
67
Neutral
€140.80B14.523.94%25.33%12.54%
67
Neutral
€27.49B11.7119.49%2.37%3.70%24.02%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DE:HNR1
Hannover Rueck
244.20
-2.06
-0.83%
DE:ALV
Allianz
379.20
80.20
26.82%
DE:MUV2
Munich Reinsurance
517.60
15.66
3.12%
DE:TLX
Talanx AG
108.80
29.83
37.78%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 13, 2026